Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mandatory discard situations Discard immediately if you observe any of the following
No direct trial evidence No published clinical trial has evaluated the four-peptide KLOW combination together, and the doses cited above are extrapolated from individual-component research and community protocols, not validated as a synergistic dose for the blend
Each 500 mcg dose equals 20 units
Central Nervous System Research Studies in murine models of traumatic brain injury propose that BPC-157 may attenuate some of the consequences of injury, including hemorrhage severity, edema, and survival rates in early post-injury periods
The KLOW Blend is a four-peptide research formulation combining GHK-Cu (copper tripeptide), BPC-157 (gastric pentadecapeptide), TB-500 (Thymosin Beta-4 fragment), and KPV (alpha-MSH C-terminal tripeptide)
Available evidence suggests that both peptides exert pleiotropic effects on wound healing, angiogenesis, tissue regeneration, and inflammatory modulation
US$ 24.75
.jpg)
&srotate=0)
US$ 27.98
US$ 23.82
US$ 26.89
US$ 19.99
US$ 28.88
US$ 24.68
US$ 29.21
